[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
December 2015

Primary Tumor Resection in Metastatic Colorectal Cancer: Please Pass the Salt

Author Affiliations
  • 1Department of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston
  • 2Department Health Services Research, The University of Texas, MD Anderson Cancer Center, Houston
 

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Oncol. 2015;1(9):1213-1214. doi:10.1001/jamaoncol.2015.2757

Treatment of metastatic colorectal cancer has evolved greatly over the past several decades. Once considered a universally fatal diagnosis, development of new systemic therapies have improved prognoses for many patients. There is an increasing interest in incorporating primary tumor resection, historically considered only palliative, into treatment algorithms for management of the primary tumor in metastatic disease. However, data examining the benefit of resection remain conflicting, and so the debate continues.

×